Skip to content
★ Sign in to follow
이
Insider activity · 24 months1 buy0 salesCumulative net flow
Total declarations
9
Company
1
▲ Purchases (7 ops.)
€53k
▼ Sales (1 ops.)
—

Latest filing published 21 Aug 2026 for 지투지바이오.

Filing timeline

BuySale
이희용

Insider track record

Disclosed buys
7
Disclosed sells
1
Signal history

No signal scores available.

Closed purchases

Market purchases
7

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

Since each purchase

  • Filed 27 Mar 2026 · 226 days ago · €53k
    -37.8%
    Entry ₩71,900 · Close 07 Oct 2026 ₩44,700
  • Filed 19 Mar 2026 · 234 days ago
    -49.9%
    Entry ₩89,200 · Close 07 Oct 2026 ₩44,700

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

이희용: trading record in brief

이희용 (chief executive) discloses dealings in 지투지바이오 to DART (FSS). We count 9 filings; the first trade dates from 14 August 2025 and the latest from 21 August 2026.

Both buying and selling appear: 7 purchases worth €53k, against 1 sale. The amount is not disclosed for 7 filings. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. So far in 2026, the count stands at 5 purchases and 1 sale.

On 1 out of 6 purchases, another insider of the same company was buying within the same 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

The latest filing, published on 21 August 2026, reports a transaction in 지투지바이오. The latest purchase dates back some time: it was published 156 days ago, on 5 June 2026. Between a trade and the moment it shows up on DART (FSS), the median delay is 7 days. That lag is the time during which only the insider knows about the trade. These figures are compiled from regulatory filings published by DART (FSS). They describe what insiders did and are not a recommendation.

Companies and markets linked to 이희용

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations9 total
  • Other(filed)
    0DART
  • ▲
    대량보유자Executives(filed)지투지바이오
    0DART
    142,888 sharesKRXDART:20260605000612
    Canonical exit: 3 Sept 2026 (T+90)
  • ▲
    대량보유자Executives(filed)지투지바이오
    0DART
    2,834,838 sharesKRXDART:20260605000604
    Canonical exit: 3 Sept 2026 (T+90)
  • ▼
    대량보유자Executives(filed)지투지바이오
    0DART
    82,845 sharesKRXDART:20260605000597
  • ▲
    대량보유자Executives(filed)지투지바이오
    0DART
    1,526,926 sharesKRXDART:20260605000587
    Canonical exit: 3 Sept 2026 (T+90)
  • ▲
    대표이사Executives지투지바이오
    92M KRW48DART
    1,200 shares@ ₩77,000.000.013% mcap100.0% of flowShareKRXDART:20260327000290
    Canonical exit: 23 Jun 2026 (T+90)
  • ▲
    Executives지투지바이오
    0DART
    2,834,838 sharesKRXDART:20260319001184
    Canonical exit: 10 Jun 2026 (T+90)
  • ▲
    Executives지투지바이오
    0DART
    1,203,200 sharesShareKRXDART:20251106000268
    Canonical exit: 4 Feb 2026 (T+90)
  • ▲
    대량보유자Executives지투지바이오
    0DART
    1,526,926 sharesKRXDART:20250908000073
    Canonical exit: 12 Nov 2025 (T+90)

9 of 9 declarations